Quality in Pathology QuIP GmbH

Excellence in science, leading in methods, professional and independent, efficient organisation

Lead Panel and Panel Institutes

QuIP-network – Overview of the Lead Panel and Panel Institutes

Latest news

QuIP GmbH offers the Proficiency Test IDH1/IDH2 Mutation Analysis in Gliomas (MolPath) 2025.

Read more

Please find below the recordings of the feedback online seminar ESR1 mutation analysis in breast cancer (liquid biopsy) from 25.02.2025 with M. Sc. Christoph Jonas (University Hospital Cologne), Dr. rer. nat. Jana Fassunke (University Hospital Cologne) and Dr. rer. nat. Anna-Lena Volckmar (University Hospital Heidelberg) divided into four short, topic-specific videos.

Read more

QuIP GmbH offers the Proficiency Test Nontuberculous Mycobacteria (MolPath) 2025.

Read more

QuIP GmbH offers the Proficiency Test PIK3CA/AKT1/PTEN Mutation Analysis (MolPath) 2025.

Read more
0 years

Quality in Pathology

Excellence in science, leading in methods, professional and independent, efficient organization

Quality in Pathology QuIP GmbH – is the provider of quality in pathology in Germany. QuIP supports pathologists and pharmaceutical companies, as well as diagnostics providers in comparing and optimising their research results. At the same time, QuIP continually develops methods to enhance knowledge. To this end, QuIP has been offering proficiency tests since 2004. QuIP is a joint venture of the German Society of Pathology (Deutsche Gesellschaft für Pathologie e. V. – DGP) and the Federal Association of German Pathologists (Bundesverband Deutscher Pathologinnen und Pathologen e.V. – BDP). The German Accreditation Body (DAkkS) has accredited the recurring proficiency tests at QuIP in accordance with DIN EN ISO/IEC 17043.

Our Mission

Excellence in Pathology

We achieve quality in pathology by defining standards for the best possible diagnostic performance in proficiency tests. These standards are always based on the current medical and technical state of knowledge. At the same time, the standards are aligned with transparent procedures and take economic efficiency into account .

Logo Qualitätssicherungs-Initiative Pathologie – QuIP GmbH
1999

Pathology institutes at German universities perform first profiency test.

2000

Immunohistochemical proficiency test “2000” includes an IAP workshop held in Würzburg presenting the results, more than 20 IHC proficiency tests are to follow.

2004

The Federal Association of German Pathologists (Bundesverband Deutscher Pathologen e.V. – BDP) and the German Society of Pathology (Deutsche Gesellschaft für Pathologie e. V. – DGP) found QuIP – Quality in Pathology as a common subsidiary.

2004

Proficiency tests on predictive factors for mammary carcinoma including in-situ-hybridisation (Hannover)

2008

First proficiency test (RAS) in molecular pathology conducted in Munich, followed by numerous molecular proficiency tests.

2009

Cooperation with Reference Institute for Bioanalytics (RfB) launched.

2014

European Society of Pathology (Europäische Gesellschaft für Pathologie - ESP) and QuIP agree on mutually recognising their certificates.

2016

QuIP Ltd. (QuIP GmbH) is founded by BDP and DGP.

2018

More than 30 proficiency tests are conducted, IHC and molecular pathology each account for about 50 percent.

2020

Preparing for digital proficiency tests